14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of PRQR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for ProQR Therapeutics N.V. stock price on Thursday moving between $1.84 and $2.03
(Updated on Apr 25, 2024)

Sell candidate since Apr 24, 2024 Loss -2.49% PDF

The ProQR Therapeutics N.V. stock price fell by -2.49% on the last day (Thursday, 25th Apr 2024) from $2.01 to $1.96. During the last trading day the stock fluctuated 10.49% from a day low at $1.84 to a day high of $2.03. The price has fallen in 7 of the last 10 days and is down by -14.78% for this period. Volume has increased on the last day by 166 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 202 thousand shares were bought and sold for approximately $395.93 thousand.

The stock lies in the lower part of a very wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.87 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 2.77% during the next 3 months and, with a 90% probability hold a price between $1.92 and $2.66 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

PRQR Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 18, 2024, and so far it has risen 5.38%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The ProQR Therapeutics N.V. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.96 and $2.20. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). ProQR Therapeutics N.V. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for ProQR Therapeutics N.V. stock

ProQR Therapeutics N.V. finds support from accumulated volume at $1.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.193 between high and low, or 10.49%. For the last week, the stock has had daily average volatility of 7.63%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (PRQR) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect ProQR Therapeutics N.V. to open at $1.94, and during the day (based on 14 day Average True Range), to move between $1.80 and $2.12, which gives a possible trading interval of +/-$0.165 (+/-8.40%) up or down from last closing price. If ProQR Therapeutics N.V. takes out the full calculated possible swing range there will be an estimated 16.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.95 (0.51%) than the resistance at $2.09 (6.63%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is ProQR Therapeutics N.V. stock A Buy?

The ProQR Therapeutics N.V. stock holds several negative signals and despite the positive trend, we believe ProQR Therapeutics N.V. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.434 Sell Candidate Unchanged

Predicted Opening Price for ProQR Therapeutics N.V. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$1.94 ( 0.798%) $1.96

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for PRQR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.14 9.05 %
R2 2.06 5.29 %
R1 2.02 2.97 %
Current price: 1.96
Support S1 1.87 -4.56 %
S2 1.83 -6.89 %
S3 1.75 -10.65 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.33 18.88 %
R2 2.20 12.24 %
R1 2.09 6.63 %
Current price 1.96
Support S1 1.95 -0.510%
S2 1.93 -1.53%
S3 1.90 -3.06%

FAQ

What is the symbol for ProQR Therapeutics N.V. Stock and on which exchange is it traded?
The symbol for ProQR Therapeutics N.V. is PRQR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell ProQR Therapeutics N.V. Stock?
The ProQR Therapeutics N.V. stock holds several negative signals and despite the positive trend, we believe ProQR Therapeutics N.V. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy ProQR Therapeutics N.V. Stock?
ProQR Therapeutics N.V. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy ProQR Therapeutics N.V. Stock.

What's the current price of ProQR Therapeutics N.V. Stock?
As of the end of day on the Apr 25, 2024, the price of an ProQR Therapeutics N.V. (PRQR) share was $1.96.

What is the 52-week high and low for ProQR Therapeutics N.V. Stock?
The 52-week high for ProQR Therapeutics N.V. Stock is $3.29 and the 52-week low is $1.11.

What is the market capitalization of ProQR Therapeutics N.V. Stock?
As of the Apr 25, 2024, the market capitalization of ProQR Therapeutics N.V. is 158.402M.

When is the next earnings date for ProQR Therapeutics N.V.?
The upcoming earnings date for ProQR Therapeutics N.V. is May 21, 2024.
Click to get the best stock tips daily for free!

About ProQR Therapeutics N.V.

ProQR Therapeutics N.V. ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. It primarily develops sepofarsen that is in phase II/III clinical trial illuminate trial for treating leber congenital amaurosis 10 disease; and ultevursen, which is in phase II/III clinical trial to treat USH2A-mediated retinitis pigmentosa and usher syndrome. The company also engages in... PRQR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT